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Abstract
This study was designed to evaluate the effect of drag reducer polymers (DRP) on arteries from normotensive (Wistar) and 
spontaneously hypertensive rats (SHR). Polyethylene glycol (PEG 4000 at 5000 ppm) was perfused in the tail arterial bed with 
(E+) and without endothelium (E-) from male, adult Wistar (N = 14) and SHR (N = 13) animals under basal conditions (constant 
flow at 2.5 mL/min). In these preparations, flow-pressure curves (1.5 to 10 mL/min) were constructed before and 1 h after PEG 
4000 perfusion. Afterwards, the tail arterial bed was fixed and the internal diameters of the arteries were then measured by 
microscopy and drag reduction was assessed based on the values of wall shear stress (WSS) by computational simulation. 
In Wistar and SHR groups, perfusion of PEG 4000 significantly reduced pulsatile pressure (Wistar/E+: 17.5 ± 2.8; SHR/E+: 
16.3 ± 2.7%), WSS (Wistar/E+: 36; SHR/E+: 40%) and the flow-pressure response. The E- reduced the effects of PEG 4000 
on arteries from both groups, suggesting that endothelial damage decreased the effect of PEG 4000 as a DRP. Moreover, the 
effects of PEG 4000 were more pronounced in the tail arterial bed from SHR compared to Wistar rats. In conclusion, these 
data demonstrated for the first time that PEG 4000 was more effective in reducing the pressure-flow response as well as WSS 
in the tail arterial bed of hypertensive than of normotensive rats and these effects were amplified by, but not dependent on, 
endothelial integrity. Thus, these results show an additional mechanism of action of this polymer besides its mechanical effect 
through the release and/or bioavailability of endothelial factors.
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Hypertension is a common disease that affects more 
than 40% of the adult population in developed countries 
and about 25% in emerging countries such as Brazil, and 
is associated with risk of cardiovascular morbidity and 
mortality (1). Although hypertension is of multifactorial 
origin, an increased peripheral resistance is observed in 
hypertensive patients and animal models (2). In addition, it 
is well known that drag reducer polymers (DRP) can reduce 
flow resistance (3).
The drag reduction phenomenon occurs in turbulent 
flows when friction drag is diminished by the addition of a 
few parts per million of long chain polymers, reaching up to 
80% reduction (3,4). This phenomenon has been studied 
since 1949 (5), when Toms first published his study showing 
the drag reduction phenomenon. For this phenomenon to 
occur, the polymer molecule should have specific charac-
teristics such as high molecular weight, long chains and a 
relatively linear structure. Classically, the polymer-induced 
drag-reducing effect occurs in turbulent flows, even though 
some studies have also described this effect on pulsatile 
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flows in straight and spiral pipes or in Couette flows with 
Taylor vortices at low Reynolds numbers (6,7).
There are results showing that atherosclerotic plaque 
formation in aortas from rabbits submitted to a high choles-
terol diet was reduced by using the polymer Separan AP-30 
(8). In addition, the administration of small amounts of DRP 
may decrease atherosclerosis by increasing shear stress in 
areas normally exposed to low shear stress (9). Moreover, 
it has been demonstrated that infusion of DRP solutions 
significantly improved tissue perfusion and oxygenation, 
as well as survival rate of fluid resuscitation after acute 
hemorrhagic shock (10). Furthermore, intravenous injection 
of poly-N-vinylformamide reduced vascular resistance in 
healthy Sprague-Dawley rats (11).
It is well known that hypertension amplifies vascular 
reactivity due, in part, to endothelium dysfunction leading 
to an increase in vascular resistance (12,13). Furthermore, 
in arterial vessels obtained from spontaneously hyperten-
sive rats (SHR), there is also an increase in inflammatory 
markers (14). Associated with other factors such as oxida-
tive stress and dyslipidemia, these vascular alterations 
might contribute to a high probability of the occurrence of 
atherosclerotic plaque in this disease (13). On the basis of 
these effects of DRP, we hypothesize that the use of DRP 
would reduce flow resistance in arteries of normotensive 
and hypertensive rats. Thus, the objective of the present 
study was to determine the drag reduction effect of poly-
ethylene glycol (PEG 4000), molecular mass 4000 Da, on 
the hydrodynamic or physiological mechanisms of the tail 
arterial bed of normotensive and hypertensive rats. 
Material and Methods
Viscosity 
Viscosity was determined according to the Standard 
Specifications and Operating Instructions for Glass Capillary 
Kinematic Viscometers - American Society for Testing and 
Materials (ASTM D446). To measure viscosity, we used the 
Ubbelohde viscometer with the following characteristics: 
size number of 0C and an approximate constant of 0.003 
(mm2/s2). The measurements were performed using a 
Krebs-Hanseleit nutrient solution in the presence of 5000 
ppm of PEG 4000 (Synth, Brazil) at 37 ± 0.02°C.
Kinematic viscosity was determined as follows: the 
viscometer was loaded with PEG 4000 (5000 ppm) diluted 
in Krebs Hanseleit solution until the liquid meniscus located 
between the minimum and maximum filled lines marked 
on the reservoir. The viscometer was then inserted into 
a constant temperature bath for 20 min for the sample to 
reach the bath temperature. Suction was applied until the 
liquid reached the center of the bulb. Next, suction was 
removed and the liquid sample was allowed to flow freely 
and the time for the meniscus to pass between two markers 
was measured. Thus, kinematic viscosity can be calculated 
by multiplying efflux time by the viscometer constant. This 
procedure was repeated six times.
Experimental animals
Four-month-old male Wistar rats (N = 14) and SHR 
(N = 13) weighing 250-300 g were obtained from colonies 
maintained in the animal facilities of Departamento de 
Fisiologia e Biofísica, Instituto de Ciências Biomédicas, 
Universidade de São Paulo. Rats were housed at constant 
room temperature, humidity, and light cycles (12/12-h 
light-dark), had free access to tap water, and were fed 
standard chow ad libitum. The investigation conformed 
to the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH 
Publication #85-23, revised 1996) and to the guidelines 
of the Committee on Care and Use of Laboratory Animal 
Resources of Instituto de Ciências Biomédicas, Univer-
sidade de São Paulo.
Perfusion of the tail arterial bed
The isolated and perfused tail arterial bed of normoten-
sive and hypertensive rats was used to study the effects 
of DRP as described by França et al. (15). The rats were 
anesthetized intraperitoneally (ip) with a mixture of ket-
amine, xylazine, and acepromazine (64.9, 3.2, and 0.78 
mg/kg, respectively), and received 500 U heparin ip. After 
10 min, a 1-cm strip of the tail artery was dissected and 
cannulated near the base of the tail using a 24G catheter 
filled with Krebs-Hanseleit solution. The tail was then sev-
ered from the body, placed in a tissue bath, and perfused 
with Krebs-Hanseleit bicarbonate buffer (KHB) containing 
27.2 mM NaHCO3, 119 mM NaCl, 1 mM NaH2PO4, 1.2 
mM MgSO4, 5 mM KCl, 1.25 mM CaCl2, 11 mM glucose, 
and 30 µM EDTA, pH 7.4, bubbled with 5% CO2-95% O2 
at 37 ± 0.5°C. The tail was cut approximately 1 cm from 
the tip to avoid microcirculation and venous return. The 
flow was provided by a peristaltic pump (Milan, Brazil) at 
2.5 mL/min. The perfusion pressure was measured us-
ing a Utah pressure transducer (Utah Medical Products, 
USA) connected to the peristaltic pump and to the arterial 
cannula. The data were recorded by an interface software 
for computer data acquisition with a Windaq™ Waveform 
Browser (DATAQ Instruments, USA) at sample acquisition 
rate of 70 Hz. Because the flow rate was the same in the 
presence and absence of PEG 4000, changes in perfusion 
pressure represented changes in vascular resistance ac-
cording to the Poiseuille equation:
4
128 LQp
d
µ∆ =
π                                           
             (Eq. 1)
where Δp is the differential pressure between the extremi-
ties of the vessel, µ is the dynamic viscosity, L is the vessel 
length, Q is the volumetric flow rate, and d is the vessel 
diameter.
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Experimental protocols
Two protocols were used to study the drag reduction 
effect of the polymer on the tail arterial beds and flow-
response curves were constructed for physiological and 
non-physiological flow rates. To establish the baseline 
conditions, the preparation was initially perfused with KHB 
solution for 1 h at a constant flow of 2.5 mL/min (15). The 
flow rates used were 1.5, 2.5, 5.0, 7.5, and 10.0 mL/min 
for 10 min each, and the steady-state perfusion pressure 
was obtained for all flow rates. The flow rate was then re-
turned to 2.5 mL/min, and the KHB solution was changed 
to KHB containing 5000 ppm of PEG 4000. After 1 h, a new 
pressure-flow relationship was obtained as described above 
but now in the presence of PEG 4000.
To assess the role of the vascular endothelium in the 
PEG 4000 effect, endothelial damage was achieved by 
perfusing the membrane detergent CHAPS (3-[(3-cholami-
dopropyl) dimethylammonio]-1-propane sulfonate; 9 µg, 90 
µL, in bolus) (Sigma, USA) at a flow rate of 2.5 mL/min. 
Endothelial damage and vascular reactivity to a nitric oxide 
(NO) donor were assessed by comparing the responses to a 
bolus injection of acetylcholine (5 µg in 100 µL; Sigma) and 
sodium nitroprusside (5 µg in 100 µL; Sigma), respectively, 
administered before and after endothelial damage. The 
endothelium was considered to be intact if the tail artery 
bed relaxed more than 70% in response to acetylcholine, 
while endothelial damage was indicated by less than 10% 
relaxation. After a new stabilization with KHB solution at a 
constant flow of 2.5 mL/min for 45 min, pressure-flow curves 
were determined using KHB solution and KHB plus PEG 
4000 as described above.
At the end of the protocols, tail arteries were fixed for the 
measurement of internal diameter under the experimental 
conditions use, with appropriate calculations by computa-
tional analysis. Because the geometry and grid construc-
tions should be performed 
using diameters equivalent to 
those at the time of perfusion, 
pressure data were acquired. 
Thus, the tail arterial bed from 
Wistar rats and SHR was fixed 
by perfusion with Bouin’s solu-
tion at the same flow rate as 
used in in vitro protocols (2.5 
mL/min) for 8 h. Next, the tail 
artery was totally dissected 
and cut into three segments, 
embedded in paraffin and 
transversely cut at 5 µm. The 
sections were stained with 
hematoxylin-eosin and exam-
ined by bright field microscopy 
(Carl Zeiss, Germany) for the 
determination of the luminal 
diameters.
Computational analysis - geometry and grid
Because hemodynamic wall shear stress (WSS) has 
been reported to affect endothelial function and vascular 
tone, it was important to quantify it in the arteries used in 
the present study. However, a simple Poiseuille flow model 
could not be used because of the tapered geometry and 
therefore the WSS distribution was determined by compu-
tational fluid dynamic simulation. The artery geometry was 
obtained from the average proximal and distal diameters of 
4-5 tail samples of each group as described above, together 
with measurements of the length of these vessels. The 
average length was approximately 110 mm. The geometry 
and the grid were generated by the preprocessor (Gambit 
2.3.16, Fluent Inc., USA) and three boundary layer meshes 
having a total thickness of 0.3 mm were created in the vi-
cinity of the wall to better resolve the shear gradients. The 
total number of nodes used for the generated mesh was 
78,166, giving rise to 331,077 computational tetrahedron 
volumes (Figure 1). 
Computational parameters and flow equations
The assumptions made about the nature of the flow 
were that it is 3-dimensional, unsteady, isothermal (37°C), 
with no external forces applied. For the computational 
analysis, the arterial wall was considered to be rigid and 
impermeable. The perfusing solution was considered to be 
a Newtonian liquid with constant density, with ρ assumed to 
be 1000 kg/m3. The inlet and outlet discharge was assumed 
to be equal. The mean pulsatile pressure curves obtained 
by the average of 10 complete pulsatile cycles from each 
group and experimental condition (Figure 2) were used as 
the inlet pressures in the numerical model for calculating 
WSS distribution. The distribution of WSS along the vessel 
length was plotted for the mean maximum value of pulsa-
tile perfusion pressure representative of each group and 
 
 
Boundary layer 
Figure 1. Unstructured grid of the tail artery with a boundary layer.
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experimental condition. A fundamental consequence of 
the viscous property of fluids is that in fluid flow there can 
be no step change in velocity at any point within the flow 
field. The reason for this is that the velocity gradient at a 
point is a measure of the rate of deformation of the fluid 
element at that point, which is resisted by the viscosity 
of the fluid. In particular, at the interface between a fluid 
and a solid boundary, such as the inner wall of a tube, the 
velocity of the fluid in contact with the wall must be the 
same as the velocity of the wall, otherwise there would 
be a step change in velocity at that point. This so-called 
no-slip condition is a fundamental condition that must be 
satisfied in any analysis of viscous flow. Thus, the no slip 
condition was applied to all walls. All the computational 
parameters defined in the preprocessor were exported 
to the solver Fluent 6.2.16. The mathematical equations 
governing the flow are:
. 0V∇ =

    Continuity                                             
 (Eq. 2)
( ) 2. pV V V∇∇ = − + ν∇ρ
  2
  
Navier-Stokes           (Eq. 3)
where V  is the velocity vector, ρ is the density, and p is the 
pressure. Discretization of these equations at each control 
volume involved an upwind scheme. The set of algebraic 
equations was solved iteratively using a procedure based 
on the semi-implicit SIMPLE algorithm. Convergence was 
Figure 2. Effect of PEG 4000 perfused at the flow rate of 2.5 mL/min on the pulsatile pressure acquired from tail 
arterial beds with intact endothelium (E+) (A and B, respectively) and after endothelial damage (E-) of Wistar rats 
and spontaneously hypertensive rats (SHR) (C and D, respectively). KHB = Krebs-Hanseleit-buffered solution. 
Relative time was calculated as actual time (t1) divided by total time (tt). N = 4-6 animals in each group. *P < 0.05 
for KHB vs KHB + PEG (paired Student t-test). Differences were analyzed concerning peak pressure, delta of 
pulsatile pressure, and area under the pressure curve.
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achieved when the changes of the mass and of all veloc-
ity components, from iteration to iteration, were less than 
10-4. Preliminary simulations were performed for all artery 
models under investigation in order to obtain information in 
terms of grid independence, which means that all models 
were independent of size of the control volume.
Calculation of wall shear stress distribution
WSS is determined from the velocity gradient at the 
wall as follows:
n
u
w ∂
∂= µτ
                                                            
(Eq. 4)
where µ is the dynamic viscosity, u is the tangential veloc-
ity at the wall, and n is the unit vector perpendicular to the 
wall. The unit used for shear stress is Pascal (Pa) from 
the International System of Units. Pascal is defined as one 
Newton per square meter (1 Pa = 1 N/m2) and one Pascal 
is equivalent to ten dynes/cm2 (1 Pa = 10 dyn/cm2).
Drag reduction
Reynolds numbers (Re) were calculated based on the 
following volumetric flow rates: 1.5, 2.5, 5.0, 7.5, and 10 
mL/min (Re = 100, 173, 346, 520, and 694, respectively). 
Drag reduction was calculated using the WSS along the 
vessel according to Equation 5:
100%sp cp
sp
DR x
∆ − ∆=
∆
τ τ
τ    
                                       (Eq. 5)
where DR is the percentage of drag reduction, and Δτsp 
and Δτcp are the shear stress without and with the polymer, 
respectively. Re was calculated using Equation 6:
4Re Q
vd
=
π                                                                
(Eq. 6)
where Q is the volumetric flow rate, ν is the kinematic 
viscosity, and d is the mean tube diameter.
Statistical analysis
Data are reported as means ± SEM, with N indicating 
the number of observations. Values were analyzed by one- 
or two-way analysis of variance (ANOVA). When ANOVA 
revealed significant difference, the Bonferroni post hoc test 
was applied. The level of significance was set at 0.05.
Results
Viscosity measurements
Viscosity was measured with Glass Capillary Kine-
matic Viscometers. The value of kinematic viscosity (ν)
was obtained by multiplying the instrument constant (C) 
by efflux time (Δt):
C tν = ∆                                                                   (Eq. 7)
whose value was 0.75 x 10-6 ± 0.0006 m2/s.
Internal arterial diameters
Active diameters obtained from tail arteries under 
the pulsatile volumetric flow rate of 2.5 mL/min were 
considered to contain intact structural and functional 
endothelium, as detected by microscopic visualization of 
endothelial cells and by functional experiments where the 
tail arterial bed was able to relax under acetylcholine infu-
sion (data not shown). As shown in Figure 3A, the internal 
diameter of the proximal portion of the tail artery (base of 
tail) did not differ between Wistar rats and SHR (Wistar: 
535 ± 13 vs SHR: 531 ± 19 µm, P > 0.05), whereas the 
diameter of the intermediate and distal portions of SHR 
tail arteries were significant smaller than those of normo-
tensive rats (intermediary - Wistar: 424 ± 33 vs SHR: 305 
± 16 µm, P < 0.05, and distal - Wistar: 348 ± 12 vs SHR: 
228 ± 10 µm, P < 0.05). It is important to state that in 
both groups there was a continuing reduction in internal 
diameter from the base to the tip of the tail (Figure 3A), 
which was associated with an increase in vessel media 
layer/lumen ratio in the distal portion (Figure 3B). In ad-
dition, it is important to emphasize that these changes 
were more expressive in tail arteries from SHR than from 
Wistar rats (Figure 3B).
Perfusion pressure and flow-response curves
Perfusion with PEG 4000 was able to decrease the main 
parameters of pulsatile pressure in all groups and experi-
mental conditions (with (E+) or without (E-) endothelium), 
as shown Figure 2. Statistical analysis showed a significant 
decrease in minimum and maximum peak pressures, as 
well as in the delta of pulsatile pressure (Figure 2). 
Figure 4A shows the pressure-flow relationship in 
isolated and perfused tail arterial beds obtained by plot-
ting mean perfusion pressure (MPP) in response to 
increasing flow rates of KHB solution perfusion before 
and after endothelial damage. MPP levels increased with 
increasing perfusion flow rate (from 1.5 to 10 mL/min) in 
both experimental groups and in all conditions evaluated 
(Figure 4A). However, the pressure-flow relationship in the 
tail arterial bed with intact endothelium from SHR exhibited 
higher rises in MPP in response to increasing flow rates 
compared the tail arterial bed of normotensive rats (Figure 
4A). Interestingly, endothelial damage by CHAPS caused 
the tail arterial bed from Wistar rats to present higher flow-
induced MPP increments, reaching the behavior of the 
tail arterial bed from the hypertensive group (Figure 4A). 
In contrast, when the endothelium was damaged in SHR 
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preparations, no changes were noted in pressure-flow 
relationship (Figure 4A). 
One-hour perfusion with PEG 4000 in KHB solution 
(Figure 4B) was able to decrease MPP levels in pressure-
flow response in the tail arterial bed with intact endothelium 
from both groups. However, SHR preparations presented 
a greater reduction than Wistar preparations (Figure 4B). 
Two-way ANOVA showed a significant interaction in flow-
response curves between SHR/E+ and SHR/
E+/PEG 4000 conditions. Figure 4C shows 
the effect of PEG 4000 in the absence of 
endothelium. After endothelial damage, as 
described above, similar increases in MPP 
induced by increasing flow rates were noted in 
both Wistar and SHR groups, and PEG 4000 
perfusion similarly reduced these responses 
in both groups (Figure 4C). 
Wall shear stress
Figure 5 shows the WSS distribution cal-
culated along the length of the tail artery from 
Wistar and SHR rats under all experimental 
conditions at a flow of 2.5 mL/min. Computa-
tional simulation estimated that WSS values 
increased along the vessel wall due to diam-
eter reduction, as demonstrated in Figure 3. 
In Wistar rats, WSS increased from 2.30 to 
23.60 Pa (from the beginning to the end of 
the vessel; Figure 5A) but, after endothelium 
removal, WSS levels increased along the tail 
artery length (from 2.84 to 29.52 Pa; Figure 
5C). As shown in Figure 5B and D, simulation 
of WSS data acquired in experiments on SHR 
vessels with and without endothelium also 
showed a similar behavior. However, in con-
trast to what was observed for Wistar rats, in 
tail arterial beds from SHR, these levels were 
closely similar both in the presence and in the 
absence of endothelial cells, ranging from 3.23 
to 32.91 and from 3.22 to 33.24 Pa, respectively 
(Figure 5B and D). 
Figure 5A and B show the WSS in the 
presence and absence of PEG 4000 in the tail 
arterial bed with intact endothelium from Wistar 
rats and SHR. Interestingly, WSS was lower 
in the presence of PEG 4000 in both groups, 
but a more expressive reduction was found in 
SHR (compare Figure 5A and B). Figure 5C 
and D graphically present the behavior of WSS 
in the presence and absence of PEG 4000 in 
simulations of data acquired from experiments 
with damaged endothelium. In these situations, 
PEG 4000 was also able to reduce the shear 
stress along the vessel wall in both Wistar 
rats and SHR. Although this modulating effect 
of PEG 4000 occurred in both groups and in 
both conditions (before and after endothelial 
damage), this effect was more significant in 
the presence of endothelial cells.
Figure 3. A, Active internal diameters of tail arteries from Wistar rats (N = 4 
animals) and spontaneously hypertensive rats (SHR, N = 5 animals) fixed at 
a volumetric flow rate of 2.5 mL/min. *P < 0.05 vs proximal portion; #P < 0.05 
vs Wistar rats (two-way ANOVA followed by the Bonferroni post hoc test). B, 
Photomicrograph of transverse sections of proximal and distal tail artery from 
Wistar rats and SHR. Magnification: 10X. Inset panels in the proximal tail artery 
photomicrographs of Wistar and SHR are amplified images showing the en-
dothelial (E), medium (M) and adventitial (A) layers of the artery. 
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Drag reduction
The relative drag reduction calculated from WSS along 
the vessel length caused by PEG 4000 perfusion is illustrated 
in Figure 6 (data calculated from computational simulation 
results reported in Figure 5). The addition of PEG 4000 to 
the perfusion solution produced a marked reduction in the 
resistance to flow, which was constant along the length of 
the vessel for all groups and experimental conditions. The 
effect of PEG 4000 on percent drag reduction was slightly 
higher in the tail arterial bed with endothelium from SHR 
(40%) compared to Wistar rats (36%). Furthermore, the drag 
reduction effect was reduced by endothelial damage in both 
groups (Figure 6). In the absence of endothelial cells, PEG 
4000 induced a 28% drag reduction in the tail arterial bed 
of Wistar rats and a 24% reduction in the tail arterial bed 
of SHR according to computational simulations.
Figure 4. Flow-pressure relationship in tail arterial beds. A, Before (E+) and after (E-) endothelial damage on tail arterial 
beds from SHR (N = 7 animals) and Wistar rats (N = 6 animals); B, in the absence and presence of PEG 4000 in tail arterial 
beds with intact endothelium (E+) from SHR (N = 5 animals) and Wistar rats (N = 7 animals); C, effect of PEG 4000 after 
endothelial damage (E-) on tail arterial beds from SHR (N = 7 animals) and Wistar rats (N = 6 animals). MPP = mean perfu-
sion pressure. #P < 0.05 vs Wistar; *P < 0.05 vs PEG effectiveness; §P < 0.05 interaction between PEG effect on Wistar rats 
and SHR (two-way ANOVA followed by the Bonferroni post hoc test). 
774 K.L. Bessa et al.
www.bjournal.com.brBraz J Med Biol Res 44(8) 2011
Discussion
In the present investigation, the effects of PEG 4000 on 
the tail arterial beds of normotensive and spontaneously 
hypertensive rats were studied both in the presence and in 
the absence of endothelial cells, and computational analysis 
of shear stress and drag reduction along the vessel wall 
was carried out. The data suggest that PEG 4000 acts dif-
ferently in the two rat strains, with its effects on vascular 
perfusion pressure or pressure-flow response being more 
pronounced in the tail arterial bed from hypertensive rats. 
In addition, the effect of PEG 4000 on drag reduction was 
amplified in the presence of endothelial cells. To the best of 
our knowledge, this is the first time that these phenomena 
are shown for PEG 4000.
It is well known that DRP, like PEG 4000, can effectively 
decrease resistance to flow without affecting fluid viscosity 
or density (5). These polymers have been investigated and 
used for various industrial and engineering applications 
including crude oil transport through pipelines, firefighting, 
and reducing drag on ships and submarines (16). When 
Figure 5. Distribution of wall shear stress along the vessel wall from the base (0 mm) to the end (110 mm) simu-
lated for the mean of the maximum value of pulsatile cycle represented in Figure 2 at a flow of 2.5 mL/min. N = 
4-6 animals in each group. A and B, Effect of PEG 4000 on the wall shear stress (Pa = Pascal) along the wall 
of the tail arterial bed with intact endothelium (E+) from Wistar rats and spontaneously hypertensive rats (SHR), 
respectively; C and D, effect of endothelial damage (E-) on PEG-induced changes in wall shear stress in the tail 
arterial beds from Wistar rats and SHR, respectively.
Figure 6. Percent drag reduction by PEG 4000 (derived from the 
computer simulated graphs in Figure 5) along the vessel length in 
Wistar rats (circles) and spontaneously hypertensive rats (SHR, 
triangles), before (open symbols) and after endothelium damage 
(filled symbols). Drag reduction values along the vessel length 
were higher in the presence of endothelium than after damage, 
and in the tail arterial bed from SHR compared to Wistar rats.
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applied to animal models of atherosclerotic plaque these 
polymers showed beneficial hemodynamic effects including 
delay/prevention of the development of atherosclerosis in 
animals kept on an atherogenic diet (8). The literature has 
reported that DRP are described as long-chain polymers 
with a molecular weight above 1,000,000 Da (10). How-
ever, almost all tests reported were performed in an in vitro 
circulating system using rigid glass tubes. A previous study 
by our group using an in vitro circulating system (silicon 
tubes) showed no drag reduction concerning laminar and 
turbulent flows with PEG 4000 (5000 ppm) (17). On the 
other hand, the present results showed drag reduction 
also using PEG 4000 (5000 ppm) in an in vitro circulating 
system of isolated tail arterial beds. Thus, the drag reduc-
tion phenomenon may be based on hydrodynamic as well 
as physiological mechanisms.
In the present study, perfusion pressure was altered in 
the perfused vascular bed, with a consequent increased 
vascular resistance in experiments conducted on hyper-
tensive rats compared to control Wistar rats. These char-
acteristics are suggestive of the well-known pathological 
changes that occur in the arterial wall of SHR (18,19). 
Thus, the high intra-arterial pressure per se is sufficient 
to induce the lack of NO-mediated vasodilatation present 
in hypertension, contributing to the intensification of WSS 
and vascular resistance (20,21). Notably, in the presence 
of PEG 4000, the perfusion pressure of isolated tail arteries 
from both normal and hypertensive animals was decreased, 
reflecting a reduction in vascular flow resistance. This 
result agrees with the hypothesis of Huang et al. (22) that 
a reduction in pressure can contribute to improving the 
vessel response.
Our protocol evaluating the effect of endothelial cells on 
vascular reactivity to flow rate demonstrated higher values 
of perfusion pressure after endothelial damage with CHAPS 
only in the tail arterial bed from Wistar rats. Specifically, the 
tail arterial bed from Wistar rats without endothelial cells 
behaved as the tail arterial bed from SHR in the presence 
or absence of endothelial cells. This can explain why 
the negative endothelial modulation of the flow-induced 
response in the tail arterial bed was lower in SHR than 
in Wistar rats (20,23). In fact, the concept of endothelial 
dysfunction in hypertension has been well established, and 
plays an important role in impaired or blunted physiological 
vascular responses (13,24). Interestingly, the presence 
of intact endothelium may also be very significant for the 
effects of PEG. Although PEG 4000 perfusion was able to 
reduce the pressure-flow response even in the absence of 
endothelial cells, as seen in Figure 4C, this modulation was 
significantly less expressive than that obtained with intact 
endothelium (Figure 4B), suggesting that endothelial cells 
have an important role in the PEG-induced reduction of 
the pressure-flow relationship. These results support the 
importance of endothelial cells in pressure and flow regula-
tion, which play a critical role in vascular homeostasis by 
acting as vasoactive, antithrombotic and anti-inflammatory 
modulators (12,13), as well as specialized sensors of local 
changes in blood flow (25-27).
In vivo studies have demonstrated that, in the presence 
of intact functional endothelium, the circumference of ves-
sels increases under high-flow conditions and decreases 
under low-flow conditions, demonstrating the vasodilator 
effect of flow (25). This control is lost, at least in part, when 
the endothelium is intentionally damaged or in pathological 
conditions involving endothelial dysfunction, as seen in SHR 
preparations. In addition, in these situations, increases in 
flow rate were not accompanied by significant vasodilata-
tion and the perfusion pressure was markedly increased 
(28). In fact, the present results support this hypothesis, 
showing that the flow-pressure relationship in the tail arterial 
bed was shifted upwards and its slope was enhanced in 
SHR compared to Wistar rats. Moreover, the computational 
simulation study concluded that WSS increased with diam-
eter reduction along the vessel length. This generated an 
exponential relationship and also showed that WSS levels 
were higher in the tail arterial bed from SHR than from 
Wistar rats. Several studies using hypertensive animals 
have revealed morphological changes in the vascular wall 
suggesting that structural modifications added to altered 
endothelial function are not only a consequence, but also 
a cause of the development or maintenance of increased 
resistance in hypertension (18,29).
In hypertension, as well as in other pathologic condi-
tions, increases in WSS can be observed during increases 
in blood flow because higher blood pressure and reduced 
vessel diameter occur concomitantly (30). Therefore, the 
higher WSS observed in the present study for the tail arte-
rial bed from SHR occurs due to the reduction in diameter 
contributing to an increase in flow resistance, possibly due 
to excessive endothelial synthesis and release of constric-
tor factors, and/or a decrease in the synthesis, release or 
bioavailability of dilator factors such as NO, that are altered 
in hypertension (21,31,32). It is also important to mention 
that at the end of the tail arterial conduit, the WSS calcu-
lated by the simulation software was markedly increased 
up to uncommon levels. This was due to the fact that the 
computational domain does not consider collateral vessels 
arising from the main tail artery, which probably forced the 
volumetric flow rate to be exactly equal at inlet and outlet 
of the conduit.
Perfusion with PEG 4000 reduced WSS in both groups. 
Some studies have shown that other PEGs, such as PEG 
5000 or PEG 10000 were able to reduce the vasocon-
striction, lack of capillary perfusion, vascular permeability, 
leukocyte adhesion, and the increase in von Willebrand 
factor in post-ischemic reperfusion. Moreover, following 
PEG 5000 or PEG 10000 injection, there was a significant 
vasodilatation associated with an increased flow during 
early reperfusion, which might have increased membrane 
fluidity in endothelial cells as a response to the increased 
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shear stress (33). Other studies have reported that PEG 
repairs neuronal membranes and inhibits free radical 
production in in vitro and in vivo models of spinal cord 
injury (34,35). Accordingly, a possible explanation for the 
reduction in WSS in the presence of PEG 4000 is that this 
polymer makes the endothelium more responsive to shear 
stress and more resistant to oxidative stress, leading to a 
reduction in vasoconstriction. It is known that in human and 
experimental model of hypertension there is an increased 
oxidative stress in the endothelium (24,36,37) and this fact 
can negatively interfere with the NO-mediated shear stress-
induced dilation (38). On this basis, the fact that PEG 4000 
decreased WSS along the vessel supports the hypothesis 
that these polymers act favorably on vascular homeostasis 
by improving the action or the bioavailability of vasodilators 
such as NO or even decreasing the actions of free radicals 
with deleterious and vasoconstrictor effects.
The drag reduction caused by PEG 4000 differed be-
tween the two experimental groups and was also modulated 
by the presence of endothelium since in the absence of 
endothelial cells the drag reduction phenomenon decreased 
significantly. The exact in vivo mechanism of action of DRPs 
is unknown because of their complex fluid dynamic behavior 
in conjunction with the non-Newtonian physics of blood flow 
(39). Some hypotheses have been raised in the literature 
to explain the action of DRPs on the vascular system. A 
commonly accepted explanation is that DRPs could carry 
the red blood cells very close to the wall vessel, contributing 
to an increase local viscosity and stimulating NO release, 
with consequent vasodilatation (10). This assumption will 
be valid if the endothelial cells do not show endothelial 
dysfunction. In our experiments, PEG 4000 induced drag 
reduction in preparations perfused with a KHB solution 
without cells. As a result, this drag reduction phenomenon 
cannot be attributed to increased local viscosity due to any 
special red blood cell arrangement. Although drag reduction 
induced by DRPs may be intensified by endothelial cells, the 
effect of PEG 4000 was even higher in SHR preparations, 
which typically exhibit an important endothelial dysfunction, 
refuting the idea of NO release-dependent drag reduction 
by DRPs as a key mechanism. 
The present study demonstrated that PEG 4000 was 
more effective in reducing the pressure-flow response and 
WSS in the tail arterial bed of hypertensive than normo-
tensive rats. In addition, the drag reduction was greater in 
the presence of intact endothelium, indicating the further 
necessity of a better understanding of the interaction be-
tween PEG 4000 and endothelial cells in this biological 
milieu. With this knowledge, it may be possible to consider 
the usefulness of PEG solutions to reduce the unfavorable 
effects of endothelial dysfunction and vasculopathies pres-
ent in hypertension.
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